Pandemic-response adenoviral vector and RNA vaccine manufacturing. (2022)
Attributed to:
Meeting the UK demand for COVID19/SARS-CoV-2 vaccines via integrated manufacturing and supply chain optimisation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41541-022-00447-3
PubMed Identifier: 35236838
Publication URI: http://europepmc.org/abstract/MED/35236838
Type: Journal Article/Review
Volume: 7
Parent Publication: NPJ vaccines
Issue: 1
ISSN: 2059-0105